Abstract
The Forkhead Box O (Foxo) proteins represent an evolutionarily conserved family of transcription factors that play an important role in regulating processes including metabolism, longevity, and cell death/survival. How is it that a single transcription factor can initiate such divergent cellular responses? We will review the evidence that specific patterns of post-translational modifications play a key role in directing Foxo into various transcriptional readouts. This regulation appears to take on a two tiered regulatory model; with a group of well defined post-translational modifications regulating nuclear localization and transcriptional activity while a second set of modifications regulate the transcriptional specificity of Foxo
Keywords: Foxo, post-translational modifications, phosphorylation, acetylation, ubiquitination, Drosophila, Caenorhabditis, Nuclear localization sequence, DYRK1A, MST1, AMPK, SIRT1, MDM2, USP7
Current Drug Targets
Title: Regulation of Foxo-Dependent Transcription by Post-Translational Modifications
Volume: 12 Issue: 9
Author(s): Marco Boccitto and Robert G. Kalb
Affiliation:
Keywords: Foxo, post-translational modifications, phosphorylation, acetylation, ubiquitination, Drosophila, Caenorhabditis, Nuclear localization sequence, DYRK1A, MST1, AMPK, SIRT1, MDM2, USP7
Abstract: The Forkhead Box O (Foxo) proteins represent an evolutionarily conserved family of transcription factors that play an important role in regulating processes including metabolism, longevity, and cell death/survival. How is it that a single transcription factor can initiate such divergent cellular responses? We will review the evidence that specific patterns of post-translational modifications play a key role in directing Foxo into various transcriptional readouts. This regulation appears to take on a two tiered regulatory model; with a group of well defined post-translational modifications regulating nuclear localization and transcriptional activity while a second set of modifications regulate the transcriptional specificity of Foxo
Export Options
About this article
Cite this article as:
Boccitto Marco and G. Kalb Robert, Regulation of Foxo-Dependent Transcription by Post-Translational Modifications, Current Drug Targets 2011; 12 (9) . https://dx.doi.org/10.2174/138945011796150316
DOI https://dx.doi.org/10.2174/138945011796150316 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Influence of Prebiotics on the Human Immune System (GALT)
Recent Patents on Inflammation & Allergy Drug Discovery Leptin and Inflammation
Current Immunology Reviews (Discontinued) Drugs and their Interactions
Current Drug Discovery Technologies Dietary Phytochemicals in Chemoprevention of Cancer
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Self-Assembled Peptide Nanoarchitectures: Applications and Future Aspects
Current Topics in Medicinal Chemistry Radiosyntheses using Fluorine-18: The Art and Science of Late Stage Fluorination
Current Topics in Medicinal Chemistry Editorial [Hot topic: Breast Cancer: Novel Therapeutic Targets (Guest Editor: George W. Yip)]
Recent Patents on Anti-Cancer Drug Discovery Nanotechnology on Duty in Medical Applications
Current Pharmaceutical Biotechnology Dihidro-β-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania
Current Pharmaceutical Design MicroRNAs (miRNAs) as Biomarker(s) for Prognosis and Diagnosis of Gastrointestinal (GI) Cancers
Current Pharmaceutical Design Engineered Inorganic/Organic-Core/Shell Magnetic Fe<sub>x</sub>O<sub>y</sub> Nanoparticles with Oleic Acid and/or Oleylamine As Capping Agents
Current Pharmaceutical Design Ocular Complications of Drugs Used in Rheumatic Disease
Current Rheumatology Reviews The Calcium-Sensing Receptor as a Regulator of Cellular Fate in Normal and Pathological Conditions
Current Molecular Medicine Emerging Use of Nanotechnology in the Treatment of Neurological Disorders
Current Pharmaceutical Design Antitumor Activity of Polysaccharides: An Overview
Current Drug Targets Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments
Current Signal Transduction Therapy Structure, Biological Properties and Applications of Marine-derived Polysaccharides
Current Organic Chemistry Biomarkers to Assess the Targeting of DNA Repair Pathways to Augment Tumor Response to Therapy
Current Molecular Medicine Modelling Chemotherapy-induced Cardiotoxicity by Human Pluripotent Stem Cells
Current Drug Targets Array-Based Approaches for the Identification of Epigenetic Silenced Tumor Suppressor Genes
Current Genomics